Skip to main content
S 2837 115th Congress Senate Crime and Law Enforcement Administrative law and regulatory procedures Business records Civil actions and liability Congressional oversight Criminal investigation, prosecution, interrogation Criminal justice information and records Department of Justice Drug trafficking and controlled substances Intergovernmental relations Licensing and registrations Retail and wholesale trades State and local government operations

Preventing Drug Diversion Act of 2018

Introduced: May 14, 2018 Introduced by: Hassan, Margaret Wood Democratic · New Hampshire See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Jun 14, 2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 14, 2018
Read twice and referred to the Committee on the Judiciary.
May 14, 2018
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Preventing Drug Diversion Act of 2018

This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.

Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.

Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.

What's happening now June 19, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.

 Related & companion bills 2
  • HR 6779 Related bill Using Data to Prevent Opioid Diversion Act of 2018
  • HR 6 Related bill SUPPORT for Patients and Communities Act
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Grassley, Chuck
Iowa · May 23, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2837: Preventing Drug Diversion Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2837/
MLA
"S. 2837: Preventing Drug Diversion Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2837/.
Bluebook (legal)
S. 2837, 115th Cong. (2026), https://openamerica.io/bill/115-S-2837/.
Markdown link
[S. 2837: Preventing Drug Diversion Act of 2018](https://openamerica.io/bill/115-S-2837/)
Report a problem